From Clinical To Commercial: Introducing Devices Earlier To Streamline The DDC Journey

Hear from expert speakers Bill Welch and Justin Schroeder as they share practical insights on aligning early-phase planning with long-term commercial success. This session explores the advantages of introducing device strategy and selection earlier in clinical development, and how early alignment between clinical and commercial manufacturing can help reduce costs, mitigate risks, and accelerate time to market.

It also highlights the role of integrated solutions in enabling seamless scale-up from pilot to full production, along with key considerations for device assembly, packaging, and testing to support regulatory and commercial readiness. Finally, the discussion examines emerging trends in early device adoption and the evolving landscape of combination product development.